Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	38.37	57.45	26.68	44.96	10.35	11.69
Short-Term Investments	-	-	-	-	-	6.51
Trading Asset Securities	151.96	137.85	192.82	147.07	375.57	199.33
Cash & Short-Term Investments	190.32	195.3	219.5	192.02	385.92	217.53
Cash Growth	-11.96%	-11.02%	14.31%	-50.24%	77.41%	9.65%
Accounts Receivable	23.81	24.16	18.08	10.42	5.32	7.75
Other Receivables	1.5	1.19	1.29	1.33	1.59	1.43
Receivables	25.3	25.36	19.37	11.75	6.91	9.18
Inventory	36.04	34.28	26.2	29.41	21.18	16.53
Prepaid Expenses	-	-	0	0.37	0.02	-
Other Current Assets	49.28	57.47	4.64	4.7	3.12	9.32
Total Current Assets	300.95	312.41	269.71	238.25	417.14	252.56
Property, Plant & Equipment	304.9	309.45	319.15	319.82	231.46	117.98
Long-Term Investments	90.34	60.27	30.27	30.1	-	-
Other Intangible Assets	73.62	63.05	70.01	51.31	54.66	31.62
Long-Term Deferred Tax Assets	8.96	7.67	4.38	0.93	4.24	6.69
Long-Term Deferred Charges	22.95	34.12	26.61	34.56	27.16	38.43
Other Long-Term Assets	14.26	12.26	66.84	69.94	12.12	0.66
Total Assets	815.97	799.23	786.97	744.92	746.78	447.94
Accounts Payable	10.97	7.59	31.93	32.73	32.73	36.65
Accrued Expenses	6.15	15.44	18.85	16.91	14.65	13.43
Current Portion of Long-Term Debt	0.56	1.01	3.91	26.83	-	-
Current Portion of Leases	-	-	1.78	1.67	2.4	-
Current Income Taxes Payable	11.95	13.49	7.98	0.25	1.34	1.06
Current Unearned Revenue	1.3	0.7	1.2	1.45	0.86	3.89
Other Current Liabilities	6.57	9.24	2.47	1.92	2.2	1.2
Total Current Liabilities	37.48	47.48	68.12	81.77	54.18	56.23
Long-Term Debt	-	-	46.43	50.3	101.67	47.5
Long-Term Leases	-	-	1.01	2.85	6.62	-
Long-Term Unearned Revenue	50.28	51.8	35.28	6.8	8.44	4.56
Long-Term Deferred Tax Liabilities	0.25	0.29	0.26	0.62	-	-
Total Liabilities	88.02	99.57	151.11	142.34	170.92	108.3
Common Stock	66.52	66.52	66.06	66.06	66.06	49.55
Additional Paid-In Capital	468.02	463.95	441.66	436.19	436.19	259.83
Retained Earnings	203.69	179.53	126.96	99.29	70.01	26.62
Treasury Stock	-11.51	-11.51	-	-	-	-
Comprehensive Income & Other	1.23	1.18	1.18	1.04	-	-
Total Common Equity	727.95	699.66	635.86	602.58	572.26	336
Minority Interest	-	-	-	-	3.61	3.64
Shareholders' Equity	727.95	699.66	635.86	602.58	575.87	339.64
Total Liabilities & Equity	815.97	799.23	786.97	744.92	746.78	447.94
Total Debt	0.56	1.01	53.13	81.65	110.7	47.5
Net Cash (Debt)	189.77	194.29	166.36	110.37	275.22	170.03
Net Cash Growth	16.08%	16.79%	50.73%	-59.90%	61.87%	-14.30%
Net Cash Per Share	2.86	2.96	2.52	1.66	4.86	3.45
Filing Date Shares Outstanding	65.3	64.84	66.06	66.06	66.06	49.55
Total Common Shares Outstanding	65.3	64.84	66.06	66.06	66.06	49.55
Working Capital	263.47	264.93	201.59	156.48	362.96	196.33
Book Value Per Share	11.15	10.79	9.63	9.12	8.66	6.78
Tangible Book Value	654.34	636.61	565.85	551.27	517.6	304.38
Tangible Book Value Per Share	10.02	9.82	8.57	8.34	7.83	6.14
Buildings	-	-	289.32	277.02	-	-
Machinery	-	-	73.35	68.14	43.18	37.77
Construction In Progress	-	-	0.05	0.02	201.95	97.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.